February Tech Talk
Topic: “Disruptive Technologies that will transform the LifeScience Industry”
it@cork have invited some of Corks leading experts from the Pharmaceutical, Medical Device and IT Industry to explore the future and whats to be expected in the coming years.
Prof Barry O’Sullivan UCC will MC the morning’s discussion highlighting some of the recent advancements in Data Analytics, 3D Printing, Artificial Intelligence, Augmented Reality, and Robotics. To celebrate ‘Engineers Week’ which is a week-long festival of nationwide events celebrating the world of engineering in Ireland.
During the networking breakfast “Patrick Liddy, from Augmented Reality and UtilityAR will have a demonstration unit with a few Augmented Reality Headsets to allow guests experience Augmented Reality first hand and to have an insight into the amazing potential.
Today John spearheads the software services division of ActionPoint and has led the charge in exploring the HoloLens and all the benefits that Augmented and Mixed Reality can bring to pharma, biopharma, health and smart manufacturing teams both locally in Ireland and internationally.
BioMarin is at the beginning of a long road towards the leveraging of AR in business of manufacturing of medicines. Taking a three-phase approach, the technology will make a real difference to BioMarin’s patients worldwide over the coming years
Joe joined Boston Scientific in 2006 and has held positions as Director of Engineering and Production Director for the Cork facility. Prior to Boston Scientific, Joe worked in Operations and New Product introduction for Ford Motor Co. in the UK and the US.
Joe has a Bachelor’s Degree in Engineering from University College Cork and a Master’s Degree in Technology Management also from University College Cork.
Andrew began his career with Johnson & Johnson in 2014 and has a direct focus to provide global leadership for the identification, development and deployment of breakthrough front end technologies and capabilities.
Andrew has over 13 years’ experience within the medical device industry, specialising in both product Research & Development and process development from design concept to the commercialisation of medical devices for the treatment of varying disease states. Prior to joining DePuy Synthes, Andrew worked in various Manufacturing Engineering, Research & Development & Process Development engineering roles within Boston Scientific.
Andrew is an advocate and encourages a culture of innovation to challenge the status quo via disruptive technologies. “A New World of Healthcare is intersecting with a New World of Technology, within manufacturing we need to be ready for the Future”.
Professor O'Sullivan was elected a Fellow of EurAI, the European Association for Artificial Intelligence (EurAI), and a Senior Member of AAAI, the Association for the Advancement of Artificial Intelligence, in 2012. In 2014 he was elected to the board of EurAI, and was elected it's Deputy President in August 2016.
Professor O’Sullivan was President of the International Association for Constraint Programming from 2007-2012; he was Chair of the Artificial Intelligence Association of Ireland from 2007-2016; coordinator of the European Research Consortium for Informatics and Mathematics Working Group on Constraints; and Council Member of the Analytics Society of Ireland, which is a member of the International Federation Of Operational Research Societies. He was the first Irish scientist to give an Invited Talk at AAAI, the conference of the Association for the Advancement of Artificial Intelligence. In 2013 he received a UCC Leadership Award and won the Association for Constraint Programming Distinguished Service Award in 2014.